Clinical trial
Application of Wharton's Jelly-derived Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis
NCT02881476 is registered in ClinicalTrials.gov with University of Warmia and Mazury as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Wharton's Jelly-derived Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis
- Lead sponsor
- University of Warmia and Mazury
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- November 30, 2015
- Completion date
- December 31, 2018
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.